Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Appendix A - Compendium of Psittacosis (Chlamydiosis) Control, 1997

DIAGNOSTIC METHODS FOR AVIAN CHLAMYDIOSIS Histopathologic Findings

In birds that have avian chlamydiosis (AC), cloudy air sacs and enlarged liver and spleen are usually observed, but no specific, gross lesion is pathognomonic. Laboratory diagnostic procedures include polymerase chain reaction (PCR), antigen-capture enzyme-linked immunosorbent assay (ELISA), and the chromatic or immunologic staining of tissue-impression smears to identify organisms. Isolation of the etiologic agent, Chlamydia psittaci, from spleen, liver, air sacs, pericardium, heart, or intestines is the optimal diagnostic verification.

Culture Technique

Culture technique is a specific diagnostic procedure that allows the recovery of the etiologic agent. Chlamydia organisms are obligate intracellular bacteria that must be isolated in tissue culture, mice, or chick embryos. Specialized laboratory facilities and training are necessary both for reliable identification of chlamydial isolates and for protection of the microbiologists. Consequently, few laboratories perform chlamydial cultures.

In live birds, depending on which clinical signs they exhibit, combined cloacal and choanal-swab specimens should be collected, refrigerated, and sent to the laboratory packed in ice, but not frozen. The proper handling of samples is critical for maintaining the viability of organisms for culture, and a special transport medium is required. Veterinarians should contact their specific diagnostic laboratory for procedures required for submission of specimens for isolation.

Live birds being screened for C. psittaci may not shed the microorganism daily. Therefore, to reduce laboratory costs, serial specimens should be collected for 3-5 consecutive days and pooled before being cultured. Tissue samples from the liver and spleen are the preferred necropsy specimens for isolation of C. psittaci. When legal actions may result from chlamydiosis cases, use of culture is recommended to avoid limitations associated with other tests.

Serologic Tests

A major problem with serologic testing is the interpretation of results. A positive serologic test result is evidence that the bird was infected by C. psittaci in the past, but it does not prove that the bird currently has active disease. False-negative results may occur for birds that have acute infection when they are sampled before seroconversion. Antibiotic treatment may diminish the antibody response.

Serologic diagnostic methods used to identify antibodies to C. psittaci include complement-fixation (CF) tests, modified-direct CF tests, latex-agglutination tests, elementary-body agglutination (EBA) tests, and microimmunofluorescence tests. A single testing method may not be adequate because of the diversity of reactions with immunoglobulins from the various avian species. Therefore, the use of a combination of antibody- and antigen-detection methods for the diagnosis of chlamydiosis is recommended, particularly when only one bird is tested. When specimens are obtained from a single bird, serologic testing is most useful when a) signs of disease and the history of the flock or aviary are considered and b) paired samples of sera are examined and the results are compared with the white blood cell counts and liver-enzyme activities of healthy birds. Either a greater than fourfold increase in titer or a combination of a titer and antigen identification is needed to confirm a diagnosis of chlamydiosis.

Some of the advantages/disadvantages of several of the serologic tests for antibodies are as follows:

Direct CF Test

Direct CF is more sensitive to antibody activity than are agglutination methods. No commercial antigen is available. False-negative results are possible in specimens from small psittacine birds (e.g., budgerigars, young African grey parrots, and lovebirds). High titers may persist after treatment and complicate interpretation of subsequent tests. Modified direct CF is more sensitive than direct CF.

Latex Agglutination

Antigen currently is not available. As a result, other methods are recommended for testing for antibody for C. psittaci.

Elementary-Body Agglutination

EBA is commercially available and can detect early infection. Titers greater than or equal to 10 in budgerigars, cockatiels, and lovebirds and titers of greater than or equal to 20 in larger birds are interpreted by the laboratory as indicating current infection. However, positive titers may persist after treatment is completed, and EBA is performed only by a single laboratory.

Tests for Antigen Immunofluorescent-Staining Tests

Monoclonal or polyclonal antibodies, fluorescein-staining techniques, and fluorescent microscopy are used to identify elementary bodies (i.e., infectious agents) in impression smears from dead birds. When used with cloacal or fecal smears, the test sensitivity and specificity are questioned by some authorities. The test is most useful if the bird is shedding antigen. Its advantages are that it gives rapid results and does not require live, viable organisms. Laboratory experience is important for accurate interpretation of immunofluorescent stains.

ELISA

Two of the ELISA tests (i.e., IDEIA{registered} and Kodak Surecell{registered}) currently being used to identify C. psittaci were originally developed for identification of the lipopolysaccharide antigen on C. trachomatis, which is a human pathogen. The sensitivity and specificity of these tests for identifying C. psittaci are not precisely known. Because of intermittent shedding, the sensitivity may be low in symptomatic birds. Moreover, some tests may be falsely positive because of cross-reaction with other bacteria. The test results must be evaluated in conjunction with other clinical findings. If a bird has a positive ELISA result but is clinically healthy, the veterinarian should attempt to verify that the bird is shedding antigen through isolation of the organism. When a clinically ill bird has a negative ELISA result, a diagnosis of AC cannot be excluded without further testing (e.g., isolation, serologic testing, or fluorescent antibody).

Additional Tests

Additional tests are in use or under development, including the elementary-body agglutination test, microagglutination test, microimmunofluorescence, and PCR. However, peer-reviewed reports on such tests currently are not available.

Laboratories that Provide AC Testing

The National Association of State Public Health Veterinarians can provide a list of laboratories that offer avian chlamydia testing. Address requests to the Association at RSA Tower, Ste. 1310, P.O. Box 303017, Montgomery, AL 36130-3017.



Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.


All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #